Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Virpax Pharmaceuticals Inc/
Recent news which mentions Virpax Pharmaceuticals Inc/
Lab Notes: AnPac dips into real estate with diversification strategy; Mineralys closes $220.8M IPO
February 17, 2023
Tickers
INNO
Tags
Haohan Xu
Biotech
Brendan Mosher
From
Business Journals
Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
July 08, 2022
Tickers
INNO
Tags
Nancy E/ Rawson
Health Care
Anthony P/ Mack
From
Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
May 06, 2022
Tickers
INNO
Tags
Endo International plc
Mel Sorensen
Inno
From
Business Journals
Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug
April 29, 2022
Tickers
INNO
Tags
George A/ Diaz
Health Care
Joseph Truitt
From
Business Journals
Virpax shares rise on expanded licensing deal for experimental drug
March 15, 2022
Tags
Insurance
Biotech
Health Care
From
Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
January 21, 2022
Tickers
INNO
Tags
Elizabeth Tarka
Hospitals
Health Care
From
Business Journals
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
December 23, 2021
Tickers
INNO
Tags
Biotech
Roundup
Lannett Co/ Inc/
From
Business Journals
Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
December 10, 2021
Tickers
INNO
Tags
Inno
Arbutus Biopharma Corporation
Insurance
From
Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
September 24, 2021
Tickers
INNO
Tags
Peters A/ Jones
Saar Gill
Health Care
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.